Glucose Clinical Trials

144 recruitingLast updated: June 19, 2026

There are 144 actively recruiting glucose clinical trials across 35 countries. Studies span Not Applicable, Phase 2, Phase 4, Phase 1, Phase 3, Early Phase 1. Top locations include New York, New York, United States, Aurora, Colorado, United States, Boston, Massachusetts, United States. Updated daily from ClinicalTrials.gov.


Glucose Trials at a Glance

144 actively recruiting trials for glucose are listed on ClinicalTrialsFinder across 6 cities in 35 countries. The largest study group is Not Applicable with 94 trials, with the heaviest enrollment activity in New York, Aurora, and Boston. Lead sponsors running glucose studies include University of Alabama at Birmingham, Georgia State University, and Arizona State University.

Treatments under study

About Glucose Clinical Trials

Looking for clinical trials for Glucose? There are currently 5 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Glucose trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Glucose clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 144 trials

Recruiting
Not Applicable

SucroMet Nutritional Intervention Trial

Glucose metabolismOverweight/Obesity
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud120 enrolled1 locationNCT07656298
Recruiting
Not Applicable

Predictive Value of Glycemic Parameters Measured With the FSL Pro iQ During ACS

Cardiovascular EventAcute Coronary SyndromeContinuous Glucose Measurement+1 more
University Hospital, Montpellier850 enrolled9 locationsNCT06014112
Recruiting

Impact of Shift Work on Glucose and Lipid Metabolism of Hospital Workers

Shift-work DisorderChronodisruptionGlucose and Lipid Metabolism
Olga Ramich (formerly Pivovarova)48 enrolled2 locationsNCT07426211
Recruiting
Phase 3

Semaglutide for the Treatment of Glucose Intolerance in Women With Prior Gestational Diabetes

Glucose Intolerance After a Recent History of Gestational Diabetes
Universitaire Ziekenhuizen KU Leuven252 enrolled13 locationsNCT05569772
Recruiting

Brain Metabolism Observed at 3 Tesla or 7 Tesla in Health and Metabolic Disease

EpilepsyGlucose Metabolism DisordersGlut1 Deficiency Syndrome 1+4 more
Weill Medical College of Cornell University20 enrolled2 locationsNCT05085704
Recruiting
Not Applicable

Personalized Meal Timing and Walking Based on Glucose Patterns in Adults With Prediabetes

PrediabetesPrediabetes (Insulin Resistance, Impaired Glucose Tolerance)Prediabetes or Diabetes
Shifa International Hospital105 enrolled1 locationNCT07618663
Recruiting

Dumping Syndrome After Esophagectomy

EsophagectomyContinous Glucose MeasurementDumping syndrome
Samsung Medical Center30 enrolled1 locationNCT07605481
Recruiting
Not Applicable

The Impact of Overnight Nutrition Support on Sleep and Circadian Rhythm Disruption in the ICU

SleepGlucose IntoleranceFeeding Patterns
Massachusetts General Hospital30 enrolled1 locationNCT04737200
Recruiting
Not Applicable

Effect of Low Dose Galactose on Glycaemia and Glucose Kinetics

Glucose
University of Bath25 enrolled1 locationNCT07599683
Recruiting
Phase 2

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance

Cystic FibrosisDiabetesPancreatic Insufficiency+1 more
University of Pennsylvania30 enrolled2 locationsNCT04731272
Recruiting
Not Applicable

Night Owl Metabolism

OverweightPrediabetesImpaired Glucose Tolerance
Johns Hopkins University70 enrolled1 locationNCT06507722
Recruiting

Glucose-Level During Endurance Exercise

Glucose metabolism
University of Ulm100 enrolled1 locationNCT07543705
Recruiting
Not Applicable

A Study Of Starting Strength Barbell Training

Blood PressureLipid ProfileFasting Glucose
Mayo Clinic200 enrolled1 locationNCT07578285
Recruiting
Not Applicable

Animal and Plant Proteins and Glucose Metabolism

Metabolic SyndromeGlucose Metabolism DisordersMetabolic Syndrome, Protection Against
University of Missouri-Columbia100 enrolled1 locationNCT03994367
Recruiting

Metabolic Control in Anesthesia and Surgery

Surgical Procedure, UnspecifiedAnesthesiaContinuous Glucose Monitoring+2 more
Zealand University Hospital100 enrolled1 locationNCT07573930
Recruiting
Not Applicable

Slowly Digestible Carbohydrates for GLP-1 Secretion

Blood GlucoseGLP - 1Satiety+2 more
Purdue University19 enrolled1 locationNCT07572513
Recruiting
Phase 3

meChANisms and sAfety of SGLT2 Inhibition in peRitoneal dialYsis

Kidney DysfunctionEnd-stage Kidney DiseasePeritoneal Dialysis Complication+2 more
University Health Network, Toronto20 enrolled1 locationNCT05715814
Recruiting
Not Applicable

Enjoying Affordable and Tasty Food Together

Depressive symptomatologyQuality of LifeBlood Pressure+7 more
University of Massachusetts, Lowell120 enrolled1 locationNCT07036757
Recruiting
Not Applicable

Stable Isotopes- Adults With Obesity

Protein metabolismGlucose metabolismObese Patients (BMI ≥ 30 kg/m²)
University of Illinois at Urbana-Champaign8 enrolled1 locationNCT07020741
Recruiting
Phase 2

Regulation of Endogenous Glucose Production by Central KATP Channels

Diabetes MellitusGlucose Metabolism Disorders
Albert Einstein College of Medicine100 enrolled1 locationNCT03540758